X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC LTD with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ACTAVIS (US) - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC LTD   ACTAVIS
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
ACTAVIS
Dec-14
ALEMBIC LTD/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs7219,470-   
Low Rs3411,876-   
Sales per share (Unadj.) Rs4.73,506.0-  
Earnings per share (Unadj.) Rs6.1-437.5-  
Cash flow per share (Unadj.) Rs6.2321.7-  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.77,604.3-  
Shares outstanding (eoy) m267.03265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.34.5 252.0%   
Avg P/E ratio x8.7-35.8 -24.2%  
P/CF ratio (eoy) x8.548.7 17.4%  
Price / Book Value ratio x1.32.1 63.2%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,1394,167,411 0.3%   
No. of employees `000NA21.6 0.0%   
Total wages/salary Rs m2070-   
Avg. sales/employee Rs ThNM43,159.0-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-5,385.8-  
INCOME DATA
Net Sales Rs m1,255932,235 0.1%  
Other income Rs m370-2,327 -15.9%   
Total revenues Rs m1,625929,908 0.2%   
Gross profit Rs m111119,759 0.1%  
Depreciation Rs m38201,863 0.0%   
Interest Rs m229,404 0.0%   
Profit before tax Rs m442-113,835 -0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0-8,350 0.0%   
Tax Rs m24-5,852 -0.4%   
Profit after tax Rs m1,630-116,333 -1.4%  
Gross profit margin %8.912.8 68.9%  
Effective tax rate %5.45.1 105.4%   
Net profit margin %129.8-12.5 -1,040.5%  
BALANCE SHEET DATA
Current assets Rs m1,867491,168 0.4%   
Current liabilities Rs m591358,206 0.2%   
Net working cap to sales %101.614.3 712.7%  
Current ratio x3.21.4 230.3%  
Inventory Days Days9458 162.5%  
Debtors Days Days7466 111.0%  
Net fixed assets Rs m1,791113,835 1.6%   
Share capital Rs m5340-   
"Free" reserves Rs m10,3240-   
Net worth Rs m10,8582,021,983 0.5%   
Long term debt Rs m411,059,559 0.0%   
Total assets Rs m11,5913,705,630 0.3%  
Interest coverage x260.9-2.9 -9,085.7%   
Debt to equity ratio x00.5 0.7%  
Sales to assets ratio x0.10.3 43.0%   
Return on assets %14.1-2.3 -600.1%  
Return on equity %15.0-5.8 -260.9%  
Return on capital %15.2-3.0 -504.5%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Net fx Rs m-2440-   
CASH FLOW
From Operations Rs m236160,083 0.1%  
From Investments Rs m-224-383,300 0.1%  
From Financial Activity Rs m-27215,359 -0.0%  
Net Cashflow Rs m-15-7,858 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.37 Rs / USD

Compare ALEMBIC LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ALEMBIC LTD With: TORRENT PHARMA  PANACEA BIOTECH  J.B.CHEMICALS  DR. REDDYS LAB  WOCKHARDT LTD.  



Today's Market

Sensex Extends Losses; FMCG and Energy Stocks Witness Selling(12:30 pm)

After opening the day marginally lower, share markets in India extended their losses and are presently trading on a negative note.

Related Views On News

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 18, 2019 03:15 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - UNICHEM LAB COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS